PharmaVentures Monthly Podcast Series
The Role of CDMOs in a Fast Evolving Manufacturing Landscape
Listen as Jansen Jacob and Steve Garland discuss how the future role of CDMOs in biopharmaceutical manufacturing will be affected by the challenges of cost, new modalities and new innovation; cell and gene therapy (CGT), and personalised medicine.
Robust Valuations of Life Science Companies, Assets and Licensing Deals
Listen as Stephen Waterman and Kyriakos Tzafestas describe how PharmaVentures’ real-world experience is combined with valuation models, in-depth commercial insight including rigorous pricing, and best quality data sources to value companies, assets and pharma licensing deals
Review of 2022: M&A, Licensing and Fundraising
Listen as Fintan Walton, PharmaVentures’ CEO and Founder, reflects on this year’s deal trends in M&A, Licensing and Fundraising, considers the significant macroeconomic events, and offers insight into what impact they may have on the global pharma and biotech industry in 2023.
How Your Pricing and Reimbursement Strategy Affects Your Deal Making Success
Listen as PharmaVentures’ Pricing and Market Access expert, Ralph Hughes, recommends elements of a robust plan to help you achieve the best pricing and market access for your drug.
How to Acquire Companies or Assets Successfully
Listen to see how you can improve your buy side and in-licensing activities